Trinity Industries (NYSE:TRN) reported its Q4 earnings results on Thursday, February 17, 2022 at 07:15 AM.
Here's what investors need to know about the announcement.
- For the Treatment of the Symptoms of Seasonal Allergic Rhinitis and Chronic Spontaneous Urticaria (such as itchiness and hives) -
- 2.5mg/mL Oral Solution and (rapidly dispersing)10mg Orodispersible (Quick Melt)